Henry E. Pelish - Jan 31, 2025 Form 4 Insider Report for Nuvalent, Inc. (NUVL)

Role
Chief Scientific Officer
Signature
/s/ Nathan N. McConarty, attorney-in-fact
Stock symbol
NUVL
Transactions as of
Jan 31, 2025
Transactions value $
$2,714
Form type
4
Date filed
2/4/2025, 04:46 PM
Previous filing
Jan 8, 2025
Next filing
Jun 10, 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NUVL Class A Common Stock Options Exercise $2.71K +3.12K +5.2% $0.87 63.1K Jan 31, 2025 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction NUVL Stock Option (Right to Buy) Options Exercise $0 -3.12K -60.85% $0.00 2.01K Jan 31, 2025 Class A Common Stock 3.12K $0.87 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares underlying this option are fully vested.